iShares US Pharmaceuticals ETF
IHE
IHE
137 hedge funds and large institutions have $422M invested in iShares US Pharmaceuticals ETF in 2023 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% more funds holding
Funds holding: 128 → 137 (+9)
Holders
137
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$220M | |
| 2 | +$58.7M | |
| 3 | +$7.69M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$6.77M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.15M |
Top Sellers
| 1 | -$3.66M | |
| 2 | -$2.41M | |
| 3 | -$1.87M | |
| 4 |
MFG
Merit Financial Group
Alpharetta,
Georgia
|
-$1.84M |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.46M |